EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Baseline echocardiographic characteristics of patients enrolled in the randomized investigation of MitraClip device in heart failure (RESHAPE HF-2) trial: comparison with COAPT and Mitra-FR

Baseline-Echokardiografiecharakteristika von Patient:innen der randomisierten RESHAPE-HF-2-Studie mit MitraClip bei Herzinsuffizienz: Vergleich mit COAPT und Mitra-FR

Ralph Stephan Von Bardeleben, Muhammad Shahzeb Khan, Martin Geyer, Tim Friede, Javed Butler, Monika Diek, Jutta Heinrich, Marius Placzek, Roberto Ferrari, William T. Abraham, Ottavio Alfieri, Angelo Auricchio und 28 weitere

Global Cardiology · 28.06.2024 · 2 (2)

DOI: 10.4081/cardio.2024.40 ↗

Auf einen Blick

Bei 505 randomisierten Patient:innen der RESHAPE-HF-2-Studie wurden die Basis-Echokardiografien beschrieben und mit COAPT sowie MITRA-FR verglichen. Die FMR war insgesamt weniger ausgeprägt als in den Vergleichsstudien.

Fragestellung

Beschreibung der Basis-Echokardiografie von Patient:innen in RESHAPE-HF-2 im Vergleich zu COAPT und MITRA-FR.

Methode

Prospektive, randomisierte, multizentrische Studie mit 505 Patient:innen; Vergleich der Baseline-Echokardiografie zwischen RESHAPE-HF-2, COAPT und MITRA-FR.

Ergebnisse

505 randomisierte Patient:innen, mittleres Alter 70 Jahre, 20 % Frauen, mittlerer BMI 26,8 kg/m2. LVEF 31±8 %, EROA 0,25 cm2, Regurgitationsvolumen 37±12 mL, 44 % mit MR-Grad 4+.

Schlussfolgerung der Autor:innen

Die Basis-Echokardiografien in RESHAPE-HF-2 unterschieden sich von MITRA-FR und COAPT. In RESHAPE-HF-2 war die FMR weniger ausgeprägt, während die LVEF in allen Studien ähnlich war.

Kernaussagen

  • 505 randomisierte Patient:innen in RESHAPE-HF-2
  • EROA und Regurgitationsvolumen geringer als in COAPT und MITRA-FR
  • LVEF in allen drei Studien etwa 31 %

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Global Cardiology, online erschienen am 28.06.2024. Verfasst von Ralph Stephan Von Bardeleben und 39 weiteren Autor:innen. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

Auf einen BlickAbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The RESHAPE-HF2 trial is aimed at evaluating the efficacy of the MitraClip device for the treatment of clinically significant functional mitral regurgitation (FMR) in patients with heart failure (HF). This report describes the baseline echocardiographic characteristics of patients enrolled in the RESHAPE-HF2 trial compared to those enrolled in the COAPT and MITRA-FR trials.

Methods

The RESHAPE-HF2 study is a prospective, randomized, multicenter trial involving patients with symptomatic HF, a left ventricular ejection fraction (LVEF) between 20% and 50%, and moderate-to-severe or severe FMR who are ineligible for isolated mitral valve surgery, despite receiving guideline-directed therapy. Patients were randomized 1:1 to either receive the MitraClip or be placed in a control group without the intervention.

Results

For the 505 patients randomized (mean age 70 years, 20% female, mean body mass index 26.8 kg/m2), the mean LVEF in the cohort was 31±8%. The mean regurgitant volume was 37±12 mL, while mean proximal iso-velocity surface area (PISA) radius was 0.72 cm. Less than half of the patients (44%) had MR severity grade 4+. The mean effective regurgitant orifice area (EROA) among patients in RESHAPE-HF2 (0.25 cm2) was lower compared to patients in MITRA-FR (0.31 cm2) and in COAPT (0.40 cm2) trials. Regurgitant volumes in RESHAPE-HF2 were 18% lower than in than in MITRA-FR (45 mL) but 38% higher than in COAPT (27 mL). The mean LV end-diastolic volumes values in the RESHAPE-HF2, COAPT, and MITRA-FR trials were 211 mL, 193 mL, and 250 mL, respectively. Patients in RESHAPE-HF2 (41 mmHg) had a comparatively lower right ventricular systolic pressure than patients in MITRA-FR (54 mmHg) and in COAPT (44 mmHg). Patients in RESHAPE-HF2, MITRA-FR, and COAPT had a similar LVEF of around 31%.

Conclusions

The baseline echocardiographic characteristics of patients in the RESHAPE-HF2 trial differ from patients in the MITRA-FR and COAPT trials. Patients enrolled in RESHAPE-HF2 had moderate-to-severe FMR, characterized by a smaller PISA radius, a lesser proportion of MR severity grade of 4+, and lower mean EROA and regurgitant volumes compared to patients in COAPT and MITRA-FR trials. LVEF was largely similar across all trials. RESHAPE-HF2 is testing TEER in a third distinct cohort of patients who have less severe FMR compared to patients in COAPT trial but have high left atrial volumes. The RESHAPE-HF2 population is also echocardiographically different from the MITRA-FR cohort.

Zitieren

APA

Bardeleben, R. S. V., Khan, M. S., Geyer, M., Friede, T., Butler, J., Diek, M., Heinrich, J., Placzek, M., Ferrari, R., Abraham, W. T., Alfieri, O., Auricchio, A., Bayes-Genis, A., Cleland, J. G., Filippatos, G., Gustafsson, F., Haverkamp, W., Kelm, M., Kuck, K., …, & Chrissoheris, M. (2024). Baseline echocardiographic characteristics of patients enrolled in the randomized investigation of MitraClip device in heart failure (RESHAPE HF-2) trial: comparison with COAPT and Mitra-FR. Global Cardiology, 2(2). https://doi.org/10.4081/cardio.2024.40

Vancouver

Bardeleben RSV, Khan MS, Geyer M, Friede T, Butler J, Diek M, et al. Baseline echocardiographic characteristics of patients enrolled in the randomized investigation of MitraClip device in heart failure (RESHAPE HF-2) trial: comparison with COAPT and Mitra-FR. Global Cardiology. 2024;2(2). doi:10.4081/cardio.2024.40

BibTeX
@article{Bardeleben2024,
  author = {Bardeleben, Ralph Stephan Von and Khan, Muhammad Shahzeb and Geyer, Martin and Friede, Tim and Butler, Javed and Diek, Monika and Heinrich, Jutta and Placzek, Marius and Ferrari, Roberto and Abraham, William T. and Alfieri, Ottavio and Auricchio, Angelo and Bayes-Genis, Antoni and Cleland, John G.F. and Filippatos, Gerasimos and Gustafsson, Finn and Haverkamp, Wilhelm and Kelm, Malte and Kuck, Karl-Heinz and Landmesser, Ulf and Maggioni, Aldo P. and Metra, Marco and Ninios, Vlasis and Petrie, Mark C. and Rassaf, Tienush and Ruschitzka, Frank and Schäfer, Ulrich and Schulze, P. Christian and Spargias, Konstantinos and Vahanian, Alec and Zamorano, Jose Luis and Zeiher, Andreas and Karakas, Mahir and Koehler, Friedrich and Lainscak, Mitja and Öner, Alper and Mezilis, Nikolaos and Theofilogiannakos, Efstratios K. and Ninios, Ilias and Chrissoheris, Michael},
  title = {Baseline echocardiographic characteristics of patients enrolled in the randomized investigation of MitraClip device in heart failure (RESHAPE HF-2) trial: comparison with COAPT and Mitra-FR},
  journal = {Global Cardiology},
  year = {2024},
  volume = {2},
  number = {2},
  doi = {10.4081/cardio.2024.40}
}
Kostenlos starten →